PT - JOURNAL ARTICLE AU - Kanno, Hiroshi AU - Zhou, Yuqi AU - Nishikawa, Masako AU - Xiao, Ting-Hui AU - Suzuki, Takuma AU - Ibayashi, Yuma AU - Harmon, Jeffrey AU - Takizawa, Shigekazu AU - Hiramatsu, Kotaro AU - Nitta, Nao AU - Kameyama, Risako AU - Peterson, Walker AU - Takiguchi, Jun AU - Shifat-E-Rabbi, Mohammad AU - Zhuang, Yan AU - Yin, Xuwang AU - Mohammad Rubaiyat, Abu Hasnat AU - Deng, Yunjie AU - Zhang, Hongqian AU - Miyata, Shigeki AU - Rohde, Gustavo K. AU - Iwasaki, Wataru AU - Yatomi, Yutaka AU - Goda, Keisuke TI - Understanding microvascular thrombosis in COVID-19 via massive single-cell imaging of circulating platelets AID - 10.1101/2021.04.29.21256354 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.29.21256354 4099 - http://medrxiv.org/content/early/2021/06/17/2021.04.29.21256354.short 4100 - http://medrxiv.org/content/early/2021/06/17/2021.04.29.21256354.full AB - A characteristic clinical feature of COVID-19 is the frequent incidence of microvascular thrombosis. In fact, COVID-19 autopsy reports have shown widespread thrombotic microangiopathy characterized by extensive diffuse microthrombi within peripheral capillaries and arterioles in lungs, hearts, and other organs, resulting in multiorgan failure. However, the underlying process of COVID-19-associated microvascular thrombosis remains elusive due to the lack of tools to statistically examine platelet aggregation (i.e., the initiation of microthrombus formation) in detail. Here we present a method for massive image-based profiling, temporal monitoring, and big data analysis of circulating platelets and platelet aggregates in the blood of COVID-19 patients at single-cell resolution, to provide previously unattainable insights into the disease. In fact, our analysis of the image data from 110 hospitalized patients shows the anomalous presence of excessive platelet aggregates in nearly 90% of all COVID-19 patients. Furthermore, results indicate strong links between the concentration of platelet aggregates and the severity, mortality, and respiratory condition of patients with COVID-19. Finally, high-dimensional analysis based on deep learning shows that the disease behaves as systemic thrombosis.Competing Interest StatementN. N. and K. G. are shareholders of CYBO, Inc. The other authors have no competing interests.Funding StatementThis work was supported by AMED JP20wm0325021, JSPS Core-to-Core Program, JSPS KAKENHI grant numbers 19H05633 and 20H00317, ImPACT Program (CSTI, Cabinet Office, Government of Japan), White Rock Foundation, Ogasawara Foundation, Nakatani Foundation, Konica Minolta Foundation, and Charitable Trust Laboratory Medicine Research Foundation of Japan.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted with the approval of the Institutional Ethics Committee in the School of Medicine at the University of Tokyo [no. 11049, no. 11344] in compliance with the relevant guidelines and regulations. Written informed consent for participation in the study was obtained from the patients using an opt-out process on the webpage of the University of Tokyo Hospital. Patients who refused participation in our study were excluded. Written informed consent was obtained from the healthy subjects as well.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe source data (Source Data 1) supporting the findings of this study are available from the corresponding authors upon reasonable request.